期刊文献+

能量合剂辅助治疗对扩张型心肌病心率变异性影响

EFFECT OF ENERGY MIXTURE ON HEART RATE VARIABILITY OF DILATED CARDIOMYOPATHY
下载PDF
导出
摘要 目的能量合剂辅助治疗扩张型心肌病(DCM),观察其对心率变异性(HRV)、左室射血分数(EF值)、左室收缩末径(LVEDd)的影响。方法将DCM患者60例随机分成治疗组和对照组,各30例。对照组予以常规治疗,治疗组在此基础上加用能量合剂。所有患者治疗17 d后检测HRV、EF值、LVEDd值。结果治疗后两组HRV均升高,其中治疗组升高差值高于对照组,差别有统计学意义;治疗后两组EF值均升高,LVEDd值均降低,其中治疗组EF升高差值高于对照组,LVEDd降低差值优于对照组。结论能量合剂辅助治疗能提高DCM患者HRV,显著改善其射血分数及心脏大小,疗效优异。 Objective:To observe the clinical efficacy of energy mixture on heart rate variability(HRV),and the effects to left ventricular ejection fraction(EF)and left ventricular systolic final diameter(LVEDd).Methods:60 patients with DCM were randomly divided into treatment group and control group(30 patients each group).The control group received routine treatment,and the treatment group received energy mixture on this basis.HRV,EF and LVEDd values were detected in all patients after 17 days of treatment.Results:HRV and EF values of two groups after treatment were both increased,the increased differences in treatment group were higher than those in the control group,and it was significant for HRV.LVEDd values were lowered in two groups after treatment,and reduced difference in treatment group is better than that in control group.Conclusion:Energy mixture adjuvant therapy can enhance HRV,significantly improve the ejection fraction and heart size of the patients with DCM,the curative effect is excellent.
作者 马超 袁文金 钟明星 MA Chao;YUAN Wen-jin;ZHONG Ming-xing(Department of Pharmacy,Ganzhou People’s hospital,Ganzhou,Jiangxi 341000,China;Department of Cardiovascular Medicine,Ganzhou People’s Hospital,Ganzhou,Jiangxi 341000,China;Department of Hematology,Ganzhou People’s Hospital,Ganzhou,Jiangxi 341000,China)
出处 《井冈山大学学报(自然科学版)》 2019年第6期95-97,共3页 Journal of Jinggangshan University (Natural Science)
基金 赣州市科技局2018年指导性科技计划项目(GZ2018ZSF288)
关键词 扩张型心肌病 心率变异性 能量合剂 dilated cardiomyopathy heart rate variability energy mixture
  • 相关文献

参考文献9

二级参考文献94

  • 1程宏勇,张钲,白锋,杨彩兰,朱惠.室速发作与T波峰-末间期的关系[J].临床心电学杂志,2006,15(1):16-18. 被引量:26
  • 2王士雯.开展老年多病因心衰的临床和基础研究[J].中华老年多器官疾病杂志,2006,5(4):244-245. 被引量:33
  • 3心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:550
  • 4Heineke J,Molkentin JD.Regulation of cardiac hypertrophy by intracellular signalling pathways[J].Nat Rev Mol Cell Biol,2006,7(8):589-600.
  • 5Towbin JA,Bowles NE.The failing heart[J].Nature,2002,415(6868):227-233.
  • 6Zou Y,Song L,Wang Z,et al.Prevalence of idiopathic hypertrophic cardiomyopathy in China:a population-based echocardiographic analysis of 8 080 adults[J].Am J Med,2004,116(1):14-18.
  • 7Knoll RH,Hoshijima M,Chien KR.Mechanisms of dilated cardiomyopathies[J].Drug Discovery Today:Disease Mechanisms,2004,1(1):31-36.
  • 8Taqueti VR,Mitchell RN,Lichtman AH.Protecting the pump:controlling myocardial inflammatory responses[J].Annu Rev Physiol,2006,68:67-95.
  • 9Liu PP,Mason JW.Advances in the understanding of myocarditis[J].Circulation,2001,104(9):1076-1082.
  • 10Eriksson U,Ricci R,Hunziker L,et al.Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity[J].Nat Med,2003,9(12):1484-1490.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部